Published in Cytokine on July 25, 2012
Interleukin-22: immunobiology and pathology. Annu Rev Immunol (2015) 1.60
IL-22 in tissue-protective therapy. Br J Pharmacol (2013) 0.98
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol (2015) 0.96
Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis. Virol J (2012) 0.92
IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium. J Am Soc Nephrol (2014) 0.87
Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases. J Invest Dermatol (2013) 0.84
IFNγ-induced suppression of β-catenin signaling: evidence for roles of Akt and 14.3.3ζ. Mol Biol Cell (2014) 0.80
mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target. Indian J Dermatol (2014) 0.80
Biological and pathological activities of interleukin-22. J Mol Med (Berl) (2016) 0.80
The Role of Interleukin-22 and Its Receptor in the Development and Pathogenesis of Experimental Autoimmune Uveitis. PLoS One (2016) 0.80
Though Active on RINm5F Insulinoma Cells and Cultured Pancreatic Islets, Recombinant IL-22 Fails to Modulate Cytotoxicity and Disease in a Protocol of Streptozotocin-Induced Experimental Diabetes. Front Pharmacol (2016) 0.79
IL22/IL-22R pathway induces cell survival in human glioblastoma cells. PLoS One (2015) 0.79
IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling. Int J Clin Exp Pathol (2014) 0.78
CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis. Nat Immunol (2016) 0.77
Immunomodulatory mechanisms of action of calcitriol in psoriasis. Indian J Dermatol (2014) 0.76
Cross talk between neuroregulatory molecule and monocyte: nerve growth factor activates the inflammasome. PLoS One (2015) 0.76
Interleukin-22 Alleviated Palmitate-Induced Endoplasmic Reticulum Stress in INS-1 Cells through Activation of Autophagy. PLoS One (2016) 0.76
Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma. Dermatol Clin (2017) 0.75
AMPK/HuR-Driven IL-20 Post-Transcriptional Regulation in Psoriatic Skin. J Invest Dermatol (2015) 0.75
Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice. Antioxid Redox Signal (2016) 0.75
Emerging immunotherapies for rheumatoid arthritis. Hum Vaccin Immunother (2014) 0.75
The pathogenic role of interleukin-22 and its receptor during UVB-induced skin inflammation. PLoS One (2017) 0.75
Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun (2009) 1.65
A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther (2008) 1.46
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis (2012) 1.15
Inflammation, atherosclerosis, and psoriasis. Clin Rev Allergy Immunol (2013) 1.10
Biological therapy of psoriasis. Indian J Dermatol (2010) 1.06
SCEDOSPORIUM INFECTION IN A PATIENT WITH ANTI-TNFα THERAPY. Indian J Dermatol (2011) 1.00
Neurotrophins in skin biology and pathology. J Invest Dermatol (2006) 0.97
Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring. Clin Rev Allergy Immunol (2013) 0.95
Effective strategies for the management of pyoderma gangrenosum: a comprehensive review. Acta Derm Venereol (2015) 0.91
Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis. Metab Syndr Relat Disord (2010) 0.91
Functional role of IL-22 in psoriatic arthritis. Arthritis Res Ther (2012) 0.89
Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis. Clin Rheumatol (2015) 0.88
Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. Int J Med Sci (2009) 0.87
A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee. Int J Med Sci (2011) 0.86
Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study. Int J Med Sci (2010) 0.86
Disseminated granuloma annulare: a cutaneous adverse effect of anti-tnf agents. Indian J Dermatol (2011) 0.85
1α,25-Dihydroxyvitamin-D3-3-bromoacetate regulates AKT/mTOR signaling cascades: a therapeutic agent for psoriasis. J Invest Dermatol (2013) 0.85
NGF and its receptor system: a new dimension in the pathogenesis of psoriasis and psoriatic arthritis. Ann N Y Acad Sci (2009) 0.85
Interleukin-17-induced proliferation of fibroblast-like synovial cells is mTOR dependent. Arthritis Rheum (2011) 0.84
Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract. Mol Cell Biochem (2011) 0.83
1,25-Dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K/Akt/mTOR signaling cascade. Int Immunopharmacol (2013) 0.82
Scid mouse model of psoriasis: a unique tool for drug development of autoreactive T-cell and th-17 cell-mediated autoimmune diseases. Indian J Dermatol (2010) 0.79
Current controversies in spondyloarthritis: SPARTAN. J Rheumatol (2010) 0.77
Severe combined immunodeficiency mouse-psoriatic human skin xenograft model: a modern tool connecting bench to bedside. Indian J Dermatol Venereol Leprol (2014) 0.76
Functional significance of nerve growth factor and its receptor (TrkA) in inflammatory arthritis. Arthritis Res Ther (2010) 0.76
Authors' reply. Indian J Dermatol (2013) 0.75
Golimumab and certolizumab: the two new anti-tumor necrosis factor kids on the block. Indian J Dermatol Venereol Leprol (2010) 0.75
Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis. Curr Opin Rheumatol (2017) 0.75
Early and Delayed 99mTc-MDP SPECT/CT Findings in Rheumatoid Arthritis and Osteoarthritis. Clin Nucl Med (2017) 0.75